-+ 0.00%
-+ 0.00%
-+ 0.00%

TWOSTEP THERAPEUTICS ANNOUNCES OVERSUBSCRIBED $62.5 MILLION SERIES A FINANCING AND FDA CLEARANCE OF IND FOR FIRST-IN-CLASS PEPTIDE-DRUG CONJUGATE

Reuters·09/09/2026 13:08:47

Please log in to view news